Clinical and Radiographic Evaluation of Bioceramic Putty Mineral Trioxide Aggregate Versus Mineral Trioxide Aggregate in Pulpotomy of Immature Permanent Molars: A Randomized Clinical Trial

14422022599195

The present study aims to evaluate the clinical and radiographic success of bioceramics putty MTA versus MTA in the pulpotomy of immature permanent molars The main question it aims to answer is: Will the biocermaics putty MTA have higher clinical and radiographic success rates than MTA in pulpotomy of immature permanent molars?

2024-03-01

2025-03-01

2025-05-30

Not yet recruiting

Early phase I

22

Inclusion Criteria: * • Patients aged from 6-8 years of both sexes have young permanent molars with deep carious lesions indicated for pulpotomy. * Restorable young permanent molars with no clinical symptoms of irreversible pulpitis. * Permanent molars without any clinical sign of pulp necrosis including swelling, fistula, pain on percussion, and pathologic tooth mobility. * Permanent molars without any adverse radiographic findings including thickening of the periodontal ligament space, radiolucency at the interradicular or periapical regions, internal and external root resorption, or calcification in pulp tissue. Exclusion Criteria: * Medically compromised patients who have systemic disease. * Uncooperative patients who refuse treatment. * Permanent molars that were previously restored.

{'studyType': 'INTERVENTIONAL', 'phases': ['PHASE3'], 'designInfo': {'allocation': 'RANDOMIZED', 'interventionModel': 'PARALLEL', 'primaryPurpose': 'TREATMENT', 'maskingInfo': {'masking': 'DOUBLE', 'whoMasked': ['PARTICIPANT', 'OUTCOMES_ASSESSOR']}}, 'enrollmentInfo': {'count': 22, 'type': 'ESTIMATED'}}

2024-02-09